Annual Synthetic Biology Industry Investment Update Over $1 Billion USD Invested in Past 12 Months

DeSci - Decentralized Science
by
|
March 13, 2017

London, UK – 13 March 2016 – SynBioBeta released today its annual Industry Investment Update, which you can download here: SynBioBeta 2017 Investment Update. Report highlights include:

  • Over $1 billion USD invested in the last 12 months
  • Over 410 companies in the industry
  • Investments led by Silicon Valley tech investors
  • Tech founders are turning biology into a tech discipline
  • Falling cost of reading and writing DNA is making biology faster, better and more cost-effective to engineer
  • Synthetic biology movement is making biology easier to engineer

The industry is rapidly evolving, with tools and platforms making way for applications that include designer biomaterials, consumer products, platforms for environmental sustainability, metabolic engineering, the circular economy, hardware, software, automation and healthcare.“The global synthetic biology industry raised over 1 billion USD in 2016, and the industry continues to show very strong signs of growth,” said John Cumbers, PhD, Founder of SynBioBeta.On 4-6 April 2017, SynBioBeta, with the support of event host SynbiCITE, will once again bring together the synthetic biology community for the 5th Annual SynBioBeta London 2017 Conference at Imperial College London, UK. Press can meet and interview a number of the companies in the industry at this year’s conference.The focus of SynBioBeta London 2017 is to connect the global synthetic biology community by fostering participation and dialogue between entrepreneurs, business executives, tech practitioners, technology scouts, academics, investors, and other great minds driving the latest commercial developments in the industry.For more information on the conference, press inquiries or interview opportunities, please contact Ashley Kubis, Content Development Manager for SynBioBeta, by phone at +1-412-496-9215, by email at ashley.kubis@synbiobeta.com or on the web: www.synbiobeta.com.

About SynBioBetaSynBioBeta is the leading community of entrepreneurs, investors, policy-makers and enthusiasts devoted to the responsible growth of the synthetic biology field. They host international synthetic biology conferences and events that bring the entire community together several times each year, giving anyone the opportunity to meet with the bright minds building and shaping the bioeconomy.SynBioBeta also offers a highly specialized weekly industry e-digest, news blog and educational courses in addition to providing companies in the industry with opportunities for advertising, exhibition and sponsorships for promotion.

Related Articles

No items found.

Annual Synthetic Biology Industry Investment Update Over $1 Billion USD Invested in Past 12 Months

by
March 13, 2017

Annual Synthetic Biology Industry Investment Update Over $1 Billion USD Invested in Past 12 Months

by
March 13, 2017

London, UK – 13 March 2016 – SynBioBeta released today its annual Industry Investment Update, which you can download here: SynBioBeta 2017 Investment Update. Report highlights include:

  • Over $1 billion USD invested in the last 12 months
  • Over 410 companies in the industry
  • Investments led by Silicon Valley tech investors
  • Tech founders are turning biology into a tech discipline
  • Falling cost of reading and writing DNA is making biology faster, better and more cost-effective to engineer
  • Synthetic biology movement is making biology easier to engineer

The industry is rapidly evolving, with tools and platforms making way for applications that include designer biomaterials, consumer products, platforms for environmental sustainability, metabolic engineering, the circular economy, hardware, software, automation and healthcare.“The global synthetic biology industry raised over 1 billion USD in 2016, and the industry continues to show very strong signs of growth,” said John Cumbers, PhD, Founder of SynBioBeta.On 4-6 April 2017, SynBioBeta, with the support of event host SynbiCITE, will once again bring together the synthetic biology community for the 5th Annual SynBioBeta London 2017 Conference at Imperial College London, UK. Press can meet and interview a number of the companies in the industry at this year’s conference.The focus of SynBioBeta London 2017 is to connect the global synthetic biology community by fostering participation and dialogue between entrepreneurs, business executives, tech practitioners, technology scouts, academics, investors, and other great minds driving the latest commercial developments in the industry.For more information on the conference, press inquiries or interview opportunities, please contact Ashley Kubis, Content Development Manager for SynBioBeta, by phone at +1-412-496-9215, by email at ashley.kubis@synbiobeta.com or on the web: www.synbiobeta.com.

About SynBioBetaSynBioBeta is the leading community of entrepreneurs, investors, policy-makers and enthusiasts devoted to the responsible growth of the synthetic biology field. They host international synthetic biology conferences and events that bring the entire community together several times each year, giving anyone the opportunity to meet with the bright minds building and shaping the bioeconomy.SynBioBeta also offers a highly specialized weekly industry e-digest, news blog and educational courses in addition to providing companies in the industry with opportunities for advertising, exhibition and sponsorships for promotion.

RECENT INDUSTRY NEWS
RECENT INSIGHTS
Sign Up Now